Palisade Bio (PALI) Stock: Buy, Sell, or Hold?
PALI - Palisade Bio, Inc. Common Stock
$1.44
0.01 (0.70%)
▲
5d:
-0.69%
30d:
-27.64%
90d:
-29.41%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When PALI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PALI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PALI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PALI is currently trading at $1.44, which is considered oversold relative to its 30-day fair value range of $1.56 to $2.09.
Technical Outlook: Technically, PALI is showing sideways momentum. Immediate support is located at $1.32, while resistance sits at $1.71.
Market Sentiment: PALI scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.22 (+609.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PALI is showing sideways momentum. Immediate support is located at $1.32, while resistance sits at $1.71.
Market Sentiment: PALI scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.22 (+609.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.56 -
$2.09
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 609.9% below Wall St target ($10.22)
- CAUTION: Bottoming setup, but lagging the sector by 44% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.56 -
$2.09
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.32
Resistance Level
$1.71
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.14
Wall Street Target
$10.22
(+609.9%)
Share & Embed Analysis
Last updated: October 03, 2026 4:27 AM ET
Data refreshes hourly during market hours. Next update: 5:27 AM
Data refreshes hourly during market hours. Next update: 5:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PALI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
